Parexel

(Image: Getty/Pattanaphong Khuankaew)

Parexel launches dedicated biotech division

By Melissa Fassbender

Parexel Biotech will support emerging companies from development through commercialization with tailored services and customized guidance, says division lead.

People on the Move: Outsourcing-Pharma roundup October '18

People on the Move: Outsourcing-Pharma roundup October '18

By Melissa Fassbender

CROs this month have made significant new hires with WCG adding eight to its scientific leadership team, PPD hiring four, and BioIVT filling its new-created role of CCO.

Also, making the move from Bioclinica, David Kiger has been named...

Parexel has been acquired by Pamplona Capital. (Image: iStock/tonefotografia)

A closer look at the Parexel deal

By Jason Monteleone

Another day, another CRO acquisition – this time Parexel, a top 10 CRO, was acquired by Pamplona Capital, a large private equity firm.

Parexel looks to accelerate margin growth with low-cost labor

Parexel looks to accelerate margin growth with low-cost labor

By Zachary Brennan

CRO Parexel’s staffing numbers took center stage during its earnings call Thursday as the company re-iterated plans to lay off as many as 850 employees – mostly in higher-cost countries -- to increase its margins.

The company expects strong growth over the next year for its network of sites

Parexel expands its clinical trial site network to speed drug development

By Zachary Brennan

CRO Parexel on Wednesday announced the expansion of its clinical trial site alliance network, which includes investigator sites and Site Management Organizations (SMOs) that help the company quickly access and enroll patient populations for clients’ clinical...

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers